HIV

Pharmacist intervention greatly improves treatment adherence.

The treatment mantra for human immunodeficiency virus (HIV) is almost-perfect lifelong adherence to antiretroviral therapy (ART).

Experimental drug blocks key sites on the virus surface that attach and invade human immune cells.

Self-testing may help control global spread of HIV/AIDS.

Researchers examine how immunodeficiency diseases avoid immune system attacks.

Current HIV treatment guidelines are based on data obtained primarily from men.

Just one follow-up phone call can keep asymptomatic adolescents with sexually transmitted infections (STI) adherent to treatment.

Hepatitis C incidence rate among HIV-positive men who have sex with men grew three-fold from 1991 to 2010.

Initial price hike justified through claims the profits could fund research and development.

Medications enable the management of HIV.

Research may lead to antibody treatment to inhibit HIV.

The Bristol-Myers Squibb Foundation has announced four new grants awarded through its Secure the Future initiative that will strengthen community-based services addressing cervical cancer in Tanzania.

Thanks to the introduction of antiretroviral therapy (ART), HIV-infected individuals are living longer than ever before, with average life expectancy growing from a relatively young 56 years in 2002 to 71 today.

Study finds approximately $1 million could be saved annually through reduced workplace efficiency and attendance.

HIV patients receiving pharmacist management services reported more frequent monitoring at the start of treatment.

Researchers target new opportunities for preventive interventions.

Over the past 2 decades, advances in HIV therapy have allowed patients to manage their infection through the use of long-term medication therapy.

Pharmacist management of human immunodeficiency virus (HIV) produces earlier viral suppression in treatment-naïve patients than primary care alone.

Cell-to-cell transmission of HIV causes greater CD4 T cell death.

Experimental combination shows similar rates of HIV virologic suppression to Truvada.

Experimental drug may allow patients to take one dose per month.

HIV viral suppression at the time of birth much worse than expected.

In an effort to demonstrate the power of shared wisdom, provide a place for the HIV community to access and share information and support national HIV advocacy efforts, Janssen has announced the launch of Your Story, Your HIV Wisdom.

Tumors linked to high blood sugar can be successfully treated without affecting blood vessel growth.

Study finds substantial minority living with undiagnosed HIV infection.

Advocates seek to eradicate the disease by 2030.

Study suggests testing sites in high schools may increase the likelihood of getting an HIV test.

Pharmacists vital in helping HIV-infected women stay adherent to their treatment regimen.

Pregnancy is an important time for women with human immunodeficiency virus (HIV) to receive adequate prenatal care, antiretroviral therapy (ART), and postpartum HIV care to improve clinical outcomes for themselves and their babies.

Device may eventually detect cancer and diabetes.